Mark Coleman - Net Worth and Insider Trading
Mark Coleman Net Worth
The estimated net worth of Mark Coleman is at least $1 Million dollars as of 2024-11-13. Mark Coleman is the Director of Axsome Therapeutics Inc and owns about 14,600 shares of Axsome Therapeutics Inc (AXSM) stock worth over $1 Million. Details can be seen in Mark Coleman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Coleman has not made any transactions after 2024-05-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Coleman
Mark Coleman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Coleman owns 1 companies in total, including Axsome Therapeutics Inc (AXSM) .
Click here to see the complete history of Mark Coleman’s form 4 insider trades.
Insider Ownership Summary of Mark Coleman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AXSM | Axsome Therapeutics Inc | 2024-05-29 | director |
Mark Coleman Latest Holdings Summary
Mark Coleman currently owns a total of 1 stock. Mark Coleman owns 14,600 shares of Axsome Therapeutics Inc (AXSM) as of May 29, 2024, with a value of $1 Million.
Latest Holdings of Mark Coleman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics Inc | 2024-05-29 | 14,600 | 99.49 | 1,452,554 |
Holding Weightings of Mark Coleman
Mark Coleman Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Coleman has made a total of 4 transactions in Axsome Therapeutics Inc (AXSM) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Axsome Therapeutics Inc is the sale of 10,497 shares on May 29, 2024, which brought Mark Coleman around $789,060.
Insider Trading History of Mark Coleman
- 1
Mark Coleman Trading Performance
GuruFocus tracks the stock performance after each of Mark Coleman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Coleman is 21.51%. GuruFocus also compares Mark Coleman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Coleman within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Coleman's insider trading performs compared to the benchmark.
Performance of Mark Coleman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.34 | | | | | |
| Relative Return to S&P 500(%) | 5.51 | | | | | |
Mark Coleman Ownership Network
Ownership Network List of Mark Coleman
Ownership Network Relation of Mark Coleman
Mark Coleman Owned Company Details
What does Axsome Therapeutics Inc do?
Who are the key executives at Axsome Therapeutics Inc?
Mark Coleman is the director of Axsome Therapeutics Inc. Other key executives at Axsome Therapeutics Inc include Chief Operating Officer Mark L. Jacobson , General Counsel Hunter R. Murdock , and Chief Financial Officer Nick Pizzie .
Axsome Therapeutics Inc (AXSM) Insider Trades Summary
Over the past 18 months, Mark Coleman made 2 insider transaction in Axsome Therapeutics Inc (AXSM) with a net sale of 40,085. Other recent insider transactions involving Axsome Therapeutics Inc (AXSM) include a net sale of 80,311 shares made by Mark L. Jacobson , a net sale of 32,323 shares made by Roger Jeffs , and a net sale of 11,016 shares made by Mark E Saad .
In summary, during the past 3 months, insiders sold 11,016 shares of Axsome Therapeutics Inc (AXSM) in total and bought 0 shares, with a net sale of 11,016 shares. During the past 18 months, 163,735 shares of Axsome Therapeutics Inc (AXSM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 163,735 shares.
Axsome Therapeutics Inc (AXSM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axsome Therapeutics Inc Insider Transactions
Mark Coleman Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Coleman. You might contact Mark Coleman via mailing address: 25 Broadway, 9th Floor, New York Ny 10004.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
